Daniel Gutenberg amplifies his startup engagement with Swiss Rockets

With Daniel Gutenberg on its Board of Directors, Swiss Rockets, a catalyst for the success of biotech startups in the field of oncology, has won an experienced player in the startup scene to support their endeavours in creating the next generation of startups with breakthrough solutions. Among its portfolio companies are Rocketvax, Torqur AG and Torpedo Pharmaceutical AG.

Daniel Gutenberg, one of Switzerland's most active venture capitalists and angel investors, is known for his unique ability to identify and support unicorn startups even before they reach ten employees. His remarkable track record in growing successful companies has made him a prominent figure in the Swiss business community.

Daniel Gutenberg's journey in entrepreneurship began in 1991 when he founded Gutenberg Communication Systems, which was acquired by the Telindus Group in 2000, with Daniel Gutenberg assuming the CEO role under the new structure. During this period, he was also a member of the prestigious Young Presidents Organization (YPO), providing him with invaluable connections and insights from influential figures like Jeff Bezos and Marc Andreessen.

In 2003, he embarked on a new chapter as an investor and advisor to startups through the Swiss venture capital firm Venture Incubator Partners. His unwavering commitment to fostering innovation and supporting emerging businesses has earned him recognition within the industry. In 2011, the Swiss Private Equity & Corporate Finance Association (SECA) honoured him as the Business Angel of the Year. Additionally, he serves as a Venture Partner at VI Partners, a renowned Swiss venture capital firm, where he has been instrumental in shaping the future of technology-driven enterprises. His extensive involvement in public and private companies and organizations like YPO reflects his dedication to fostering leadership and innovation at every level.

Gutenberg is also a co-founder of the Crypto Finance Conference in St. Moritz, Switzerland, and an esteemed member of the Circle of Investors of BrainsToVentures. His involvement in these initiatives underscores his commitment to advancing the frontiers of technology and finance. Daniel Gutenberg is also a Member of the Board of Governors at Technion University in Israel.

Investments in Swiss Rockets startups
Recognizing the immense potential of Swiss Rockets AG's portfolio companies in driving positive societal impact and revolutionizing the healthcare system, Daniel Gutenberg has also made strategic investments in several of these startups. "I believe that the cutting-edge technologies being developed by Swiss Rockets AG's portfolio companies have the potential to bring about breakthrough results that will benefit society at large," said Daniel Gutenberg.

"We are honoured to have Daniel Gutenberg join our Board of Directors and invest in our portfolio companies," said Dr Vladimir Cmiljanovic, CEO and Founder of Swiss Rockets AG. "His exceptional track record and unwavering dedication to the startup ecosystem make him an invaluable addition to our team. We look forward to benefiting from his guidance, expertise, and investments as we continue to support and elevate Switzerland's biotech industry."

(Press release/RAN)